Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 2
1986 2
1987 5
1988 5
1989 1
1990 8
1991 5
1992 6
1993 5
1994 6
1995 14
1996 8
1997 10
1998 9
1999 16
2000 12
2001 14
2002 7
2003 5
2004 7
2005 4
2006 7
2007 11
2008 6
2009 4
2010 1
2011 18
2012 9
2013 7
2014 3
2015 1
2016 1
2017 3
2018 1
2019 1
2020 3
2021 2
Text availability
Article attribute
Article type
Publication date

Search Results

212 results
Results by year
Filters applied: . Clear all
Page 1
Five-year survival analysis of surgically resected gastric cancer cases in Japan: a retrospective analysis of more than 100,000 patients from the nationwide registry of the Japanese Gastric Cancer Association (2001-2007).
Katai H, Ishikawa T, Akazawa K, Isobe Y, Miyashiro I, Oda I, Tsujitani S, Ono H, Tanabe S, Fukagawa T, Nunobe S, Kakeji Y, Nashimoto A; Registration Committee of the Japanese Gastric Cancer Association. Katai H, et al. Gastric Cancer. 2018 Jan;21(1):144-154. doi: 10.1007/s10120-017-0716-7. Epub 2017 Apr 17. Gastric Cancer. 2018. PMID: 28417260
Feasibility study of alternate-day S-1 as adjuvant chemotherapy for gastric cancer: a randomized controlled trial.
Tatebe S, Tsujitani S, Nakamura S, Shimizu T, Yamane N, Nishidoi H, Kurisu Y, Kanayama H, Ogawa H, Ikeguchi M. Tatebe S, et al. Gastric Cancer. 2014;17(3):508-13. doi: 10.1007/s10120-013-0289-z. Epub 2013 Aug 15. Gastric Cancer. 2014. PMID: 23948997 Clinical Trial.
BACKGROUND: The Adjuvant Chemotherapy Trial of S-1 for Gastric Cancer established oral S-1 administration for 1 year as the standard postoperative adjuvant chemotherapy for gastric cancer in Japan. ...METHODS: Patients with Stage II or III gastric cancer who underwe …
BACKGROUND: The Adjuvant Chemotherapy Trial of S-1 for Gastric Cancer established oral S-1 administration for 1 year as the st …
Surgical resection following combination chemotherapy with oral S-1 and biweekly docetaxel in a patient with advanced gastric cancer and a prior coronary artery bypass graft with the right gastroepiploic artery: report of a case.
Kubo N, Oki E, Ohgaki K, Shibahara K, Imamura I, Sadanaga N, Morita M, Kakeji Y, Fujita K, Tsujitani S, Maehara Y. Kubo N, et al. Surg Today. 2011 Nov;41(11):1531-7. doi: 10.1007/s00595-010-4453-3. Epub 2011 Oct 4. Surg Today. 2011. PMID: 21969157 Review.
We treated this patient with two courses of combination chemotherapy using S-1 and docetaxel as induction therapy, followed by successful tumor resection. ...
We treated this patient with two courses of combination chemotherapy using S-1 and docetaxel as induction therapy, followed by succes …
Recent results of therapy for scirrhous gastric cancer.
Ikeguchi M, Miyake T, Matsunaga T, Yamamoto M, Fukumoto Y, Yamada Y, Fukuda K, Saito H, Tatebe S, Tsujitani S. Ikeguchi M, et al. Surg Today. 2009;39(4):290-4. doi: 10.1007/s00595-008-3860-1. Epub 2009 Mar 25. Surg Today. 2009. PMID: 19319634 Review.
Determinant Factors on Differences in Survival for Gastric Cancer Between the United States and Japan Using Nationwide Databases.
Ito Y, Miyashiro I, Ishikawa T, Akazawa K, Fukui K, Katai H, Nunobe S, Oda I, Isobe Y, Tsujitani S, Ono H, Tanabe S, Fukagawa T, Suzuki S, Kakeji Y, Sasako M, Bilchik A, Fujita M. Ito Y, et al. J Epidemiol. 2021 Apr 5;31(4):241-248. doi: 10.2188/jea.JE20190351. Epub 2020 Apr 11. J Epidemiol. 2021. PMID: 32281553 Free PMC article.
Surgical outcomes of elderly patients with Stage I gastric cancer from the nationwide registry of the Japanese Gastric Cancer Association.
Nunobe S, Oda I, Ishikawa T, Akazawa K, Katai H, Isobe Y, Miyashiro I, Tsujitani S, Ono H, Tanabe S, Fukagawa T, Suzuki S, Kakeji Y; Registration Committee of the Japanese Gastric Cancer. Nunobe S, et al. Gastric Cancer. 2020 Mar;23(2):328-338. doi: 10.1007/s10120-019-01000-3. Epub 2019 Aug 26. Gastric Cancer. 2020. PMID: 31451990
Optimal extent of lymph node dissection for remnant advanced gastric carcinoma after distal gastrectomy: a retrospective analysis of more than 3000 patients from the nationwide registry of the Japanese Gastric Cancer Association.
Katai H, Ishikawa T, Akazawa K, Fukagawa T, Isobe Y, Miyashiro I, Oda I, Tsujitani S, Ono H, Tanabe S, Nunobe S, Suzuki S, Kakeji Y; Registration Committee of the Japanese Gastric Cancer Association. Katai H, et al. Gastric Cancer. 2020 Nov;23(6):1091-1101. doi: 10.1007/s10120-020-01081-5. Epub 2020 May 17. Gastric Cancer. 2020. PMID: 32419120
Combination chemotherapy of S-1 and low-dose cisplatin for advanced gastric cancer.
Tsujitani S, Fukuda K, Kaibara N. Tsujitani S, et al. Gastric Cancer. 2003;6 Suppl 1:50-7. doi: 10.1007/s10120-003-0223-x. Gastric Cancer. 2003. PMID: 12775021 Clinical Trial.
BACKGROUND: A previous phase II study showed that S-1 (TS-1) was effective for advanced gastric cancers and had mild toxicity. ...Five or 10 mg CDDP was infused three times each week (days 1, 3, 5) during S-1 administration on hospitalization, and once each week (da …
BACKGROUND: A previous phase II study showed that S-1 (TS-1) was effective for advanced gastric cancers and had mild toxicity. ...Fiv …
212 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page